Synakis

Business Services · Canada · 1-10 Employees

View Company Info for Free

Overview

Headquarters

160 College Street 510, Toronto, Ontario...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Synakis

Synakis is a pre-clinical biotech startup focused on developing novel biomaterial-based treatments for ocular conditions such as retinal detachment and glaucoma. Their core technology, SNK-125, is an injectable hydrogel designed for ocular delivery, aimed at restoring vision and improving the lives of patients. The company is dedicated to creating biocompatible and biodegradable solutions to treat leading causes of blindness. Synakis actively participates in industry events to engage with the community and share advancements in ophthalmic therapies.Explore more
Synakis's Social MediaPopular SearchesSynakis CorpSynakisSIC Code 87,873NAICS Code 54,541Show more

Synakis Org Chart

Thierry Nivaggioli, Chief Executive Officer at Synakis
Canada flag for contact location.

Chief Executive Officer

PhoneEmail
Robert Devenyi, Co-Founder & Chief Marketing Officer at Synakis
Canada flag for contact location.

Co-Founder & Chief Marketing Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Synakis your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Synakis

Compare insights from companies similar to Synakis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Synakis

<$5M
1-10
Private
<$5M
2019
<$5M
1-10
Private
-
2021
ZL
Zoë LaksmanClinical Psychologist and Clinical Director
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Synakis is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Synakis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Synakis.

Synakis financials insights

Gather financial insights about Synakis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2026

Angel/Pre-Seed

$1.9M

See All Synakis's Financials Insights

Synakis Tech Stack

A closer look at the technologies used by Synakis

Synakis News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Synakis

What is Synakis's official website?
Synakis's official website is www.synakis.ca
What is Synakis's Revenue?
Synakis's revenue is <$5 Million
What is Synakis's SIC code?
Synakis's SIC: 87,873
What is Synakis's NAICS code?
Synakis's NAICS: 54,541
How many employees does Synakis have?
Synakis has 1-10 employees
What industry does Synakis belong to?
Synakis is in the industry of: Business Services, Research & Development
What is Synakis competition?
Synakis top competitors include: Laksman Doell, Armstrong Toronto, Yeoh Osteo, Erica's Wish
What technology does Synakis use?
Some of the popular technologies that Synakis uses are: Squarespace Online Stores, Adobe Typekit
What does Synakis do?

Synakis is a pre-clinical biotech startup focused on developing novel biomaterial-based treatments for ocular conditions such as retinal detachment and glaucoma. Their core technology, SNK-125, is an injectable hydrogel designed for ocular delivery, aimed at restoring vision and improving the lives of patients. The company is dedicated to creating... biocompatible and biodegradable solutions to treat leading causes of blindness. Synakis actively participates in industry events to engage with the community and share advancements in ophthalmic therapies.Read More

What are Synakis social media links?
Synakis Linkedin page
Who invested in Synakis?
Synakis has 3 investors including Canadian Glycomics Network, Toronto Innovation Acceleration Partners and Ontario Centre of Innovation.
Is Synakis a public company?
Synakis is private company therefore does not currently have an official ticker symbol
See more information about Synakis

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.